Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

May 22, 2012

Pharmacotherapy for smoking cessation

Bookmark and Share

The health benefits of smoking cessation are well documented. Smokers who quit reduce their risk of cardiovascular disease, lung disease, and cancer and increase their life expectancy substantially. While most smokers make several quit attempts before they succeed, about one in four who use any pharmacotherapy will eventually quit smoking. Evidence indicates that pharmacotherapy increases [...]

Use of prescribed drugs to treat alcohol addiction

Bookmark and Share

Alcohol-dependent patients might require medically prescribed drugs to help them in the initial stages of treatment or/and to prevent relapses.

Opioid misuse

Bookmark and Share

PHARMACOLOGY OF OPIOIDS The term ‘opioids’ refers to a class of psychoactive substances derived from the poppy plant (including opium, morphine and codeine), as well as semi-synthetic forms (including heroin) and synthetic compounds (including methadone and buprenorphine) with similar properties. Illicit use of opioids generally involves injecting, or inhaling the fumes produced by heating the [...]

Oral Bisphosphonates and Risk of Oesophageal Cancer

Bookmark and Share

Oral bisphosphonates are primarily indicated for the prevention and/or treatment of osteoporosis and products currently authorised for use in Ireland include alendronate, ibandronate and risedronate. Some oral bisphosphonates are indicated only for Paget’s disease (tiludronate) or for treatment in malignancy indications (clodronate). The Pharmacovigilance Working Party (PhVWP) of the European Medicines Agency recently reviewed new [...]

Cimzia

Bookmark and Share

Company: UCB (Pharma) Ireland Ltd. Legal category: Prescription. High Tech. Sport permitted. Active ingredient: Certolizumab pegol 200mg/ml. Description: Solution for injection in pre-filled syringe. Presentation: 2 per pack. Prices on request. Indications: Treatment of moderate to severe, active rheumatoid arthritis in combination with methotrexate (MTX) when the response to disease-modifying antirheumatic drugs including MTX has [...]

Docetaxel Actavis

Bookmark and Share

Company: Actavis Ireland Ltd. Legal category: Prescription. Hospital. Sport permitted. Active ingredient: Docetaxel 20mg/ml. Description: Concentrate for solution for infusion. Presentation: 1ml; 4ml; 7ml. Prices on request. Indications: Adjunct to operable node-positive breast cancer. Metastatic breast cancer in patients whose tumours overexpress HER2 in combination with trastuzumab without prior chemotherapy. Locally advanced or metastatic breast [...]

Mycolat

Bookmark and Share

Company: Rowex Ltd. Legal category: Prescription. High Tech. Sport permitted. Active ingredient: Mycophenolate mofetil 250mg, 500mg. Description: 250mg: Hard gelatin capsules with blue cap and orange body. 500mg: Lavender, biconvex, film-coated tablets. Presentation: 250mg-100, €97.58; 500mg-50, €97.58. Indications: In combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic [...]

Nebivolol Teva

Bookmark and Share

Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Prohibited in specific sports. Active ingredient: Nebivolol (HCl) 5mg. Description: White/off-white, round, cross-scored tablet. Presentation: 28, €9.73. Indications: Treatment of essential hypertension and of stable mild and moderate chronic heart failure (CHF) in addition to standard therapies in elderly patients 70 years or older. Pharmacology: Nebivolol is [...]

Changes to Augmentin

Bookmark and Share

GlaxoSmithKline Ireland wishes to inform you of changes made to their Augmentin range. These changes arise from a European regulatory review which concluded that there is a need to harmonise the prescribing information for Augmentin. The main changes are: • The licensed indication is dependent on the ratio of the active ingredients • A 2:1 [...]